Arkolith/Insider Trading/IOVA/Form 4

Vogt Frederick G

Interim CEO & General Counsel, DirectorIOVANCE BIOTHERAPEUTICS, INC. (IOVA) · full profile →Form 4 · filed Mar 4, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Option exercise(M)52K—$0517K
Mar 2, 2026Tax withholding(F)23K$3.79$86K494K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2026Option exercise(M)42K—$0167K
Mar 2, 2026Option exercise(M)10K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-023539) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML